SUCRALFATE Side Effects

7028225-X | Pyrexia, Rash
on Sep 23, 2010 Male patient from NETHERLANDS , 56 years of age, was diagnosed with oesophageal carcinoma and was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: pyrexia, rash (What is rash?). Sucralfate dosage: 1 Df, Single,.

7006190-9 | Bezoar
Patient was taking Sucralfate (View Usage). Patient had the following side effects: bezoar on Sep 08, 2010 from AUSTRIA Additional patient health information: Male patient , 49 years of age, . Sucralfate dosage: 6 G, Qd,.

7006080-1 | Bezoar
Adverse event was reported on Sep 08, 2010 by a Male patient taking Sucralfate (View Usage) (Dosage: 6 G, Qd,) . Location: AUSTRIA , 61 years of age, After Sucralfate was administered, patient had the following side effects: bezoar.

7006079-5 | Pulmonary Embolism
on Sep 08, 2010 Female patient from CANADA , 77 years of age, was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Sucralfate dosage: Intravenous.


7003886-X | Bezoar, Ileus
on Sep 08, 2010 Male patient from UNITED STATES , 69 years of age, was treated with Sucralfate (View Usage). Patient had the following side effects: bezoar, ileus. Sucralfate dosage: Intragastric. During the same period patient was treated with OSMOLITE (CARBOHYDRATES NOS, FATTY ACIDS NOS, MINERALS NOS, PROTEINS N (View Osmolite (carbohydrates Nos, Fatty Acids Nos, Minerals Nos, Proteins N Review and Osmolite (carbohydrates Nos, Fatty Acids Nos, Minerals Nos, Proteins N Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ALUMINUM HYDROXIDE TAB (View Aluminum Hydroxide Tab Review and Aluminum Hydroxide Tab Label ), DOCUSATE SODIUM (DOCUSATE SODIUM) (View Docusate Sodium (docusate Sodium) Review and Docusate Sodium (docusate Sodium) Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ). Patient was hospitalized.

7003885-8 | Bezoar, Jaundice, Liver Function Test Abnormal, Melaena, Parosmia, Sensation Of Foreign Body, Ulcer
Patient was taking Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: bezoar, jaundice (What is jaundice?), liver function test abnormal, melaena, parosmia, sensation of foreign body, ulcer (What is ulcer?) on Sep 08, 2010 from UNITED STATES Additional patient health information: Male patient , 42 years of age, . Sucralfate dosage: 1 G, Qid. During the same period patient was treated with FAMOTIDINE (20 Mg, Bid, Intravenous, 40 Mg, Bid, Intravenous) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

6928393-1 | Anaphylactic Shock, Infection, Neutropenia, Radiation Oesophagitis, Rash
Adverse event was reported on Aug 04, 2010 by a Male patient taking Sucralfate (View Usage) (Dosage: 1 G, Oral) was diagnosed with oesophagitis, oesophageal carcinoma and. Location: NETHERLANDS , 56 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock, infection (What is infection?), neutropenia, radiation oesophagitis, rash (What is rash?). During the same period patient was treated with PACLITAXEL (6 Mg/ml) (View Paclitaxel Review and Paclitaxel Label ), CARBOPLATIN (10 Mg/ml) (View Carboplatin Review and Carboplatin Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FOLIUMZUUR (FOLIC ACID) (View Foliumzuur (folic Acid) Review and Foliumzuur (folic Acid) Label ), DEPAKENE (View Depakene Review and Depakene Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ). Patient was hospitalized.

6898070-4 | Hypersensitivity, Off Label Use, Pyrexia, Rash
on Jul 20, 2010 Male patient from NETHERLANDS , 56 years of age, was diagnosed with oesophageal carcinoma and was treated with Sucralfate (View Usage). Patient had the following side effects: hypersensitivity, off label use, pyrexia, rash (What is rash?). Sucralfate dosage: 1 Df, Single. Patient was hospitalized.

6796293-6 | Condition Aggravated, Gastric Disorder, Product Quality Issue, Product Solubility Abnormal, Tablet Issue
on Jun 24, 2010 Female patient from UNITED STATES , 65 years of age, was diagnosed with irritable bowel syndrome (What is irritable bowel syndrome?) and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: condition aggravated, gastric disorder, product quality issue, product solubility abnormal, tablet issue. Sucralfate dosage: Take 1 Tblet Four Times Daily.

6680243-7 | Accidental Exposure, Anastomotic Complication, Device Dislocation, Device Leakage, Dialysis, Feeding Tube Complication, Gastric Perforation, Iatrogenic Injury, Postrenal Failure
Patient was taking Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, anastomotic complication, device dislocation, device leakage, dialysis (What is dialysis?), feeding tube complication, gastric perforation, iatrogenic injury, postrenal failure on Mar 29, 2010 from BELGIUM Additional patient health information: Female patient , 59 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer and. Sucralfate dosage: 5 Ml, Q4h, Intrgastric. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ).

6652823-6 | Abdominal Distension, Abdominal Pain, Erythema, Feeling Hot, Flatulence, Hyperhidrosis, Pruritus, Rash, Swelling Face
Adverse event was reported on Mar 25, 2010 by a Female patient taking Sucralfate (View Usage) (Dosage: 1 4xday Po) was diagnosed with oesophageal ulcer and. Location: UNITED STATES , 69 years of age, weighting 165.0 lb, Patient had the following side effects: abdominal distension, abdominal pain (What is abdominal pain?), erythema, feeling hot, flatulence, hyperhidrosis, pruritus, rash (What is rash?), swelling face.

6637427-3 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Malaise
on Mar 03, 2010 Male patient from JAPAN , 48 years of age, was diagnosed with adenoma benign and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal, malaise. Sucralfate dosage: 1 G, Tid, Oral. During the same period patient was treated with LANSOPRAZOLE (30 Mg, Qd, Oral) (View Lansoprazole Review and Lansoprazole Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ). Patient was hospitalized.

6602740-2 | Cardiac Arrest, Pulmonary Embolism, Rash, Respiratory Failure
on Jan 25, 2010 Female patient from GERMANY , 80 years of age, was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), pulmonary embolism (What is pulmonary embolism?), rash (What is rash?), respiratory failure. Sucralfate dosage: Single, Intravenous.

6510209-9 | Erythema Multiforme
Patient was taking Sucralfate (View Usage). Patient had the following side effects: erythema multiforme on Dec 08, 2009 from JAPAN Additional patient health information: Male patient , 18 years of age, . Sucralfate dosage: Oral.

6419921-3 | Pleural Effusion
Adverse event was reported on Oct 27, 2009 by a Female patient taking Sucralfate (View Usage) (Dosage: ) was diagnosed with oesophageal adenocarcinoma metastatic and. Location: UNITED STATES , weighting 116.6 lb, After Sucralfate was administered, patient had the following side effects: pleural effusion. During the same period patient was treated with PHENERGAN HCL (View Phenergan Hcl Review and Phenergan Hcl Label ), COMPAZINE (View Compazine Review and Compazine Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DOCETAXEL (View Docetaxel Review and Docetaxel Label ), MEGACE (View Megace Review and Megace Label ), BEVACIZUMAB (7.5 Mg/kg Day 1/22 Day Cycle) (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6239130-0 | Diarrhoea, Fatigue, Vomiting, Weight Decreased
on Jun 10, 2009 Male patient from GERMANY , child 8 years of age, was diagnosed with inflammation, oesophageal disorder and was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, fatigue, vomiting, weight decreased. Sucralfate dosage: Tid Postprandial Oral.

6090984-0 | Transient Ischaemic Attack
on Feb 19, 2009 Female patient from UNITED STATES , weighting 174.0 lb, was diagnosed with gastritis and was treated with Sucralfate (View Usage). Patient had the following side effects: transient ischaemic attack. Sucralfate dosage: 1 Tab (gram) Bid Po. Patient was hospitalized.

5990163-9 | Anaphylactic Reaction
Patient was taking Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: anaphylactic reaction on Nov 26, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, . Sucralfate dosage: .

5939900-X | Flushing, Hypertension, Oedema Peripheral
Adverse event was reported on Oct 30, 2008 by a Male patient taking Sucralfate (View Usage) (Dosage: 1 Gm Qid Po) was diagnosed with erosive oesophagitis and. Location: UNITED STATES , 63 years of age, weighting 276.0 lb, Patient experienced the following unwanted or unexpected effects: flushing, hypertension, oedema peripheral.

5929363-2 | Choking, Product Quality Issue, Retching
on Oct 23, 2008 Female patient from UNITED STATES , 57 years of age, weighting 180.0 lb, was diagnosed with ulcer (What is ulcer?) and was treated with Sucralfate (View Usage). Patient had the following side effects: choking (What is choking?), product quality issue, retching. Sucralfate dosage: 1 Tab 3x Before Meals Po.

5921880-4 | Erosive Oesophagitis, Product Quality Issue
on Oct 16, 2008 Female patient from UNITED STATES , 79 years of age, was diagnosed with ulcer (What is ulcer?) and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: erosive oesophagitis, product quality issue. Sucralfate dosage: 1gm Qid Po.

5894426-7 | Rash, Swelling
Patient was taking Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?), swelling on Sep 23, 2008 from UNITED STATES Additional patient health information: Female patient , 65 years of age, weighting 124.0 lb, . Sucralfate dosage: .

5893518-6 | Abortion Induced, Alcohol Use
Adverse event was reported on Sep 08, 2008 by a Female patient taking Sucralfate (View Usage) (Dosage: ) was diagnosed with gastritis and. Location: KOREA, REPUBLIC OF , 36 years of age, Patient had the following side effects: abortion induced, alcohol use. During the same period patient was treated with IMIDAPRIL (IMIDAPRIL) (View Imidapril (imidapril) Review and Imidapril (imidapril) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), BARNIDIPINE (BARNIDIPINE) (View Barnidipine (barnidipine) Review and Barnidipine (barnidipine) Label ), AMLODIPINE (AMLODIPINE) (View Amlodipine (amlodipine) Review and Amlodipine (amlodipine) Label ).

5893514-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatitis Acute, Liver Disorder
on Sep 08, 2008 Female patient from JAPAN , 44 years of age, was diagnosed with duodenal ulcer and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatitis acute, liver disorder. Sucralfate dosage: 10 Mg Tid. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), SODIUM ALGINATE CALCIUM GLUCONATE INJ (View Sodium Alginate Calcium Gluconate Inj Review and Sodium Alginate Calcium Gluconate Inj Label ), GLORAMIN (LEVOFLUTAMIDE, AZULENE SODIUM SULFONATE) (View Gloramin (levoflutamide, Azulene Sodium Sulfonate) Review and Gloramin (levoflutamide, Azulene Sodium Sulfonate) Label ), THIATON (TIQUIZIUM BROMIDE) (View Thiaton (tiquizium Bromide) Review and Thiaton (tiquizium Bromide) Label ). Patient was hospitalized.

5893513-7 | Liver Disorder, Reye's Syndrome
on Sep 08, 2008 Female patient from JAPAN , 28 years of age, was diagnosed with gastritis and was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, reye's syndrome. Sucralfate dosage: 900 Mg Tid Oral.

5893512-5 | Diarrhoea, Duodenal Stenosis, Small Intestine Carcinoma, Vomiting
Patient was taking Sucralfate (View Usage). Patient had the following side effects: diarrhoea, duodenal stenosis, small intestine carcinoma, vomiting on Sep 08, 2008 from FRANCE Additional patient health information: Female patient , 64 years of age, was diagnosed with duodenal ulcer and. Sucralfate dosage: 1 G Qid. During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

5875711-1 | Atrial Fibrillation, Blood Pressure Diastolic Decreased, Cardiotoxicity, Electrocardiogram Qt Prolonged, Sinus Bradycardia
Adverse event was reported on Aug 26, 2008 by a Female patient taking Sucralfate (View Usage) (Dosage: ) . Location: UNITED STATES , 65 years of age, After Sucralfate was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood pressure diastolic decreased, cardiotoxicity, electrocardiogram qt prolonged, sinus bradycardia. During the same period patient was treated with SULFAMETHOXAZOLE + TRIMETHOPRIM (View Sulfamethoxazole + Trimethoprim Review and Sulfamethoxazole + Trimethoprim Label ). Patient was hospitalized.

5828719-6 | Pruritus, Rash Erythematous, Skin Exfoliation
on Jul 18, 2008 Female patient from FRANCE , 49 years of age, was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash erythematous, skin exfoliation. Sucralfate dosage: Oral. During the same period patient was treated with MUCOMYST (Oral) (View Mucomyst Review and Mucomyst Label ). Patient was hospitalized.

5812421-0 | Hyponatraemia
on Jul 08, 2008 Female patient from FRANCE , 76 years of age, was treated with Sucralfate (View Usage). Patient had the following side effects: hyponatraemia. Sucralfate dosage: Oral. During the same period patient was treated with ZOLPIDEM TARTRATE (Oral) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), MOPRAL (OMEPRAZOLE) (Oral) (View Mopral (omeprazole) Review and Mopral (omeprazole) Label ), BETAHISTINE (BETAHISTINE) (Oral) (View Betahistine (betahistine) Review and Betahistine (betahistine) Label ), MORPHINE SULFATE (Oral) (View Morphine Sulfate Review and Morphine Sulfate Label ), PAROXETINE HCL (Oral) (View Paroxetine Hcl Review and Paroxetine Hcl Label ). Patient was hospitalized.

5809757-6 | Abortion Induced
Patient was taking Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: abortion induced on Jun 19, 2008 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 36 years of age, was diagnosed with gastritis and. Sucralfate dosage: . During the same period patient was treated with IMIDAPRIL (IMIDAPRIL) (View Imidapril (imidapril) Review and Imidapril (imidapril) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), BARNIDIPINE (BARNIDIPINE) (View Barnidipine (barnidipine) Review and Barnidipine (barnidipine) Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

5809752-7 | Hepatitis, Lymphocyte Stimulation Test Positive
Adverse event was reported on Jun 19, 2008 by a Female patient taking Sucralfate (View Usage) (Dosage: 10 Mg Tid) was diagnosed with duodenal ulcer and. Location: JAPAN , 44 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), lymphocyte stimulation test positive. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ALLOID G (SODIUM ALGINATE) (View Alloid G (sodium Alginate) Review and Alloid G (sodium Alginate) Label ), GLORAMIN (LEVOGLUTAMIDE, AZULENE SODIUM SULFONATE) (View Gloramin (levoglutamide, Azulene Sodium Sulfonate) Review and Gloramin (levoglutamide, Azulene Sodium Sulfonate) Label ), THIATON (TIQUIZIUM BROMIDE) (View Thiaton (tiquizium Bromide) Review and Thiaton (tiquizium Bromide) Label ). Patient was hospitalized.

5809751-5 | Vomiting
on Jun 19, 2008 Female patient from FRANCE , 64 years of age, was diagnosed with duodenal ulcer and was treated with Sucralfate (View Usage). Patient had the following side effects: vomiting. Sucralfate dosage: 1 G Qid. During the same period patient was treated with INIPOMP (PANTOPRAZOLE) (40 Mg Bid) (View Inipomp (pantoprazole) Review and Inipomp (pantoprazole) Label ).

5794526-6 | Liver Disorder, Reye's Syndrome
on Jun 09, 2008 Female patient from JAPAN , 28 years of age, was diagnosed with gastritis and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: liver disorder, reye's syndrome. Sucralfate dosage: 900 Mg Tid Oral.

5723024-0 | Abdominal Pain, Gastric Disorder, Hyperhidrosis, Nausea, Tremor
Patient was taking Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), gastric disorder, hyperhidrosis, nausea (What is nausea?), tremor on Apr 28, 2008 from UNITED STATES Additional patient health information: Male patient , 64 years of age, . Sucralfate dosage: One Tablet Before Meals And At Bedtime..

5679703-7 | Stevens-johnson Syndrome
Adverse event was reported on Mar 10, 2008 by a Female patient taking Sucralfate (View Usage) (Dosage: I Dosage Forms Bid; 4 Dosage Forms Qid Po) was diagnosed with gastric ulcer, pain (What is pain?), ascites, portal hypertension, oedema, hepatic cirrhosis, reflux oesophagitis and. Location: GERMANY , 68 years of age, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with IBUPROFEN (1dosage Forms, Prn Po) (View Ibuprofen Review and Ibuprofen Label ), DICLOFENAC SODIUM (1x U Po) (View Diclofenac Sodium Review and Diclofenac Sodium Label ), ALDACTONE (50 Mg, Bid; 50 Mg, Tid; 50 Mg, Bid Po) (View Aldactone Review and Aldactone Label ), DIPYRONE TAB (1 U, Prn Po) (View Dipyrone Tab Review and Dipyrone Tab Label ), OBSIDAN (PROPRANOLOL HYDROCHLORIDE) (0.5 Dosage Forms, Tid Po) (View Obsidan (propranolol Hydrochloride) Review and Obsidan (propranolol Hydrochloride) Label ), AQUAPHOR (XIPAMIDE) (20 Mg Tablets, Qd Po) (View Aquaphor (xipamide) Review and Aquaphor (xipamide) Label ), HEPA MERZ (ORNITHINE ASPARTATE) (1 Dosage Forms Syrup, Tid; 1 Dosage Forms, Tid Po) (View Hepa-merz (ornithine Aspartate) Review and Hepa-merz (ornithine Aspartate) Label ), METOCLOPRAMIDE (36 Dosage Forms Gtt, Tid Po) (View Metoclopramide Review and Metoclopramide Label ).

5589330-8 | Hepatitis Acute, Lymphocyte Stimulation Test Positive
on Dec 03, 2007 Female patient from JAPAN , 44 years of age, was diagnosed with duodenal ulcer and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: hepatitis acute, lymphocyte stimulation test positive. Sucralfate dosage: 3000 Mg. During the same period patient was treated with RABEPRAZOLE SODIUM (1 U Tablets) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), ALLOID G (SODIUM ALGINATE) (30 Ml) (View Alloid G (sodium Alginate) Review and Alloid G (sodium Alginate) Label ), GLORIAMIN (LEVOGLUTAMIDE, AZULENE SODIUM SULFONATE) (0.5 G 3 Times A Day Granules) (View Gloriamin (levoglutamide, Azulene Sodium Sulfonate) Review and Gloriamin (levoglutamide, Azulene Sodium Sulfonate) Label ), THIATON (TIQUIZIUM BROMIDE) (3 U Capsules) (View Thiaton (tiquizium Bromide) Review and Thiaton (tiquizium Bromide) Label ). Patient was hospitalized.

5589329-1 | Liver Disorder, Reye's Syndrome
on Dec 26, 2007 Female patient from JAPAN , 28 years of age, was diagnosed with gastritis and was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, reye's syndrome. Sucralfate dosage: 3 G. Patient was hospitalized.

5420701-6 | Abortion Induced, Anxiety, Gastritis
Patient was taking Sucralfate (View Usage). Patient had the following side effects: abortion induced, anxiety (What is anxiety?), gastritis on Aug 01, 2007 from KOREA, REPUBLIC OF Additional patient health information: Female patient , 36 years of age, was diagnosed with gastritis, hypertension, anxiety (What is anxiety?) and. Sucralfate dosage: Mother's Daily Dose: 250 Mg. During the same period patient was treated with IMIDAPRIL (IMIDAPRIL) (Mother's Daily Dose: 5 Mg) (View Imidapril (imidapril) Review and Imidapril (imidapril) Label ), LORAZEPAM (Mother's Daily Dose: 0,5 Mg) (View Lorazepam Review and Lorazepam Label ), BARNIDIPINE (BARNIDIPINE) (Mother's Daily Dose: 10 Mg) (View Barnidipine (barnidipine) Review and Barnidipine (barnidipine) Label ), AMLODIPINE (Mother's Daily Dose: 5 Mg) (View Amlodipine Review and Amlodipine Label ).

5411322-X | Abortion Induced
Adverse event was reported on Jul 31, 2007 by a Female patient taking Sucralfate (View Usage) (Dosage: 250 Mg Oral) was diagnosed with gastritis, hypertension, anxiety (What is anxiety?) and. Location: KOREA, REPUBLIC OF , 36 years of age, After Sucralfate was administered, patient had the following side effects: abortion induced. During the same period patient was treated with IMIDAPRIL (IMIDAPRIL) (5 Mg Oral) (View Imidapril (imidapril) Review and Imidapril (imidapril) Label ), LORAZEPAM (0.5 Mg Oral) (View Lorazepam Review and Lorazepam Label ), BARNIDIPINE (BARNIDIPINE) (10 Mg Oral) (View Barnidipine (barnidipine) Review and Barnidipine (barnidipine) Label ), AMLODIPINE (5 Mg Oral) (View Amlodipine Review and Amlodipine Label ).

5411123-2 | Hepatic Function Abnormal
on Aug 03, 2007 Female patient from JAPAN , 83 years of age, was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal. Sucralfate dosage: Oral. Patient was hospitalized.

5353065-7 |
on May 23, 2007 Female patient from KOREA, REPUBLIC OF , 36 years of age, was diagnosed with gastritis, hypertension, anxiety (What is anxiety?) and was treated with Sucralfate (View Usage). . Sucralfate dosage: 250 Mg, Oral. During the same period patient was treated with IMIDAPRIL (IMIDAPRIL) (5 Mg, Oral) (View Imidapril (imidapril) Review and Imidapril (imidapril) Label ), LORAZEPAM (0.5 Mg, Oral) (View Lorazepam Review and Lorazepam Label ), BARNIDIPINE (BARNIDPINE) (10 Mg, Oral) (View Barnidipine (barnidpine) Review and Barnidipine (barnidpine) Label ), AMLODIPINE (5 Mg, Oral) (View Amlodipine Review and Amlodipine Label ).

5353064-5 | Blood Aluminium Increased, Metal Poisoning
Patient was taking Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: blood aluminium increased, metal poisoning on May 21, 2007 from GERMANY Additional patient health information: Male patient , 43 years of age, . Sucralfate dosage: 20 Ml, Intravenous.

5323922-6 | Odynophagia, Sensation Of Foreign Body
Adverse event was reported on May 09, 2007 by a Male patient taking Sucralfate (View Usage) (Dosage: 1 Tablet By Mouth Twice A Day) . Location: UNITED STATES , 71 years of age, Patient experienced the following unwanted or unexpected effects: odynophagia, sensation of foreign body.

5300194-X | Alanine Aminotransferase Increased, Arthritis, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Chloride Decreased, Blood Cholesterol Increased, Blood Sodium Decreased, Bronchitis, Cholelithiasis
on Mar 26, 2007 Female patient from UNITED STATES , 35 years of age, was diagnosed with muscle spasms and was treated with Sucralfate (View Usage). Patient had the following side effects: alanine aminotransferase increased, arthritis (What is arthritis?), aspartate aminotransferase increased, blood alkaline phosphatase increased, blood chloride decreased, blood cholesterol increased, blood sodium decreased, bronchitis (What is bronchitis?), cholelithiasis. Sucralfate dosage: . During the same period patient was treated with ZEBETA (View Zebeta Review and Zebeta Label ), ALPRAZOLAM (3 Mg) (View Alprazolam Review and Alprazolam Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ). Patient was hospitalized and became disabled.

5292635-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Gamma-glutamyltransferase Increased, Hepatocellular Damage, Hepatotoxicity, Pruritus
on Mar 26, 2007 Female patient from ISRAEL , 62 years of age, was diagnosed with duodenal ulcer, oesophagitis and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, hepatocellular damage, hepatotoxicity, pruritus. Sucralfate dosage: 1g Tid.

5282838-4 | Hepatocellular Damage, Pruritus
Patient was taking Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: hepatocellular damage, pruritus on Mar 12, 2007 from ISRAEL Additional patient health information: Female patient , 62 years of age, was diagnosed with duodenal ulcer, oesophagitis and. Sucralfate dosage: 1g Tid.

5257578-8 | Hepatic Function Abnormal
Adverse event was reported on Feb 23, 2007 by a Female patient taking Sucralfate (View Usage) (Dosage: ) . Location: JAPAN , 83 years of age, Patient had the following side effects: hepatic function abnormal.

5110374-4 | Cold Sweat, Depressed Level Of Consciousness, Incontinence, Interstitial Lung Disease, Respiratory Arrest
on Aug 15, 2006 Male patient from JAPAN , weighting 130.1 lb, was diagnosed with large intestine carcinoma and was treated with Sucralfate (View Usage). After Sucralfate was administered, patient had the following side effects: cold sweat, depressed level of consciousness, incontinence, interstitial lung disease, respiratory arrest. Sucralfate dosage: . During the same period patient was treated with RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), OXALIPLATIN (140mg/body) (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (Bolus Then 3300 Mg/body) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (350mg/body) (View Leucovorin Calcium Review and Leucovorin Calcium Label ), NOVOLIN R (Unk) (View Novolin R Review and Novolin R Label ), KYTRIL (View Kytril Review and Kytril Label ), DECADRON (View Decadron Review and Decadron Label ).

5099817-2 | Laryngeal Oedema
on Aug 31, 2006 Male patient from ITALY , 79 years of age, was treated with Sucralfate (View Usage). Patient experienced the following unwanted or unexpected effects: laryngeal oedema. Sucralfate dosage: 4 G /day.

5087821-X | Interstitial Lung Disease
Patient was taking Sucralfate (View Usage). Patient had the following side effects: interstitial lung disease on Aug 15, 2006 from JAPAN Additional patient health information: Male patient , 69 years of age, . Sucralfate dosage: . During the same period patient was treated with RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), OXALIPLATIN (140mg/body) (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (Bolus Then 3300 Mg/body) (View Fluorouracil Review and Fluorouracil Label ), LEUCOVORIN CALCIUM (350mg/body) (View Leucovorin Calcium Review and Leucovorin Calcium Label ).